ORGANON & CO (OGN) Stock Fundamental Analysis
USA - New York Stock Exchange - NYSE:OGN - US68622V1061 - Common Stock
7.1403 USD
0 (0%)
OGN gets a fundamental rating of 5 out of 10. The analysis compared the fundamentals against 191 industry peers in the Pharmaceuticals industry. While OGN has a great profitability rating, there are quite some concerns on its financial health. OGN is valued quite cheap, but it does not seem to be growing.
1. Profitability
1.1 Basic Checks
OGN had positive earnings in the past year.
In the past year OGN had a positive cash flow from operations.
Each year in the past 5 years OGN has been profitable.
In the past 5 years OGN always reported a positive cash flow from operatings.
1.2 Ratios
Looking at the Return On Assets, with a value of 3.70%, OGN belongs to the top of the industry, outperforming 84.29% of the companies in the same industry.
OGN has a better Return On Equity (55.30%) than 98.43% of its industry peers.
OGN's Return On Invested Capital of 9.86% is amongst the best of the industry. OGN outperforms 89.01% of its industry peers.
The Average Return On Invested Capital over the past 3 years for OGN is in line with the industry average of 12.85%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 3.7% | ||
| ROE | 55.3% | ||
| ROIC | 9.86% |
ROA(3y)7.82%
ROA(5y)11.49%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)12.92%
ROIC(5y)16.57%
1.3 Margins
OGN has a Profit Margin of 7.95%. This is amongst the best in the industry. OGN outperforms 83.25% of its industry peers.
In the last couple of years the Profit Margin of OGN has declined.
OGN's Operating Margin of 21.54% is amongst the best of the industry. OGN outperforms 89.53% of its industry peers.
In the last couple of years the Operating Margin of OGN has declined.
OGN has a better Gross Margin (55.04%) than 67.54% of its industry peers.
In the last couple of years the Gross Margin of OGN has declined.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 21.54% | ||
| PM (TTM) | 7.95% | ||
| GM | 55.04% |
OM growth 3Y-8.47%
OM growth 5Y-14.29%
PM growth 3Y-14.29%
PM growth 5Y-20.08%
GM growth 3Y-2.36%
GM growth 5Y-3.89%
2. Health
2.1 Basic Checks
OGN has a Return on Invested Capital (ROIC), which is well above the Cost of Capital (WACC), which means it is creating value.
Compared to 1 year ago, OGN has more shares outstanding
The number of shares outstanding for OGN has been increased compared to 5 years ago.
OGN has a better debt/assets ratio than last year.
2.2 Solvency
Based on the Altman-Z score of 1.20, we must say that OGN is in the distress zone and has some risk of bankruptcy.
OGN has a Altman-Z score (1.20) which is comparable to the rest of the industry.
The Debt to FCF ratio of OGN is 15.60, which is on the high side as it means it would take OGN, 15.60 years of fcf income to pay off all of its debts.
Looking at the Debt to FCF ratio, with a value of 15.60, OGN is in the better half of the industry, outperforming 76.44% of the companies in the same industry.
OGN has a Debt/Equity ratio of 9.69. This is a high value indicating a heavy dependency on external financing.
Looking at the Debt to Equity ratio, with a value of 9.69, OGN is doing worse than 83.25% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 9.69 | ||
| Debt/FCF | 15.6 | ||
| Altman-Z | 1.2 |
ROIC/WACC1.56
WACC6.34%
2.3 Liquidity
OGN has a Current Ratio of 1.75. This is a normal value and indicates that OGN is financially healthy and should not expect problems in meeting its short term obligations.
OGN's Current ratio of 1.75 is on the low side compared to the rest of the industry. OGN is outperformed by 65.44% of its industry peers.
OGN has a Quick Ratio of 1.20. This is a normal value and indicates that OGN is financially healthy and should not expect problems in meeting its short term obligations.
With a Quick ratio value of 1.20, OGN is not doing good in the industry: 72.77% of the companies in the same industry are doing better.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.75 | ||
| Quick Ratio | 1.2 |
3. Growth
3.1 Past
The earnings per share for OGN have decreased by -3.91% in the last year.
OGN shows a very negative growth in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -23.48% yearly.
OGN shows a decrease in Revenue. In the last year, the revenue decreased by -1.69%.
The Revenue has been decreasing by -3.81% on average over the past years.
EPS 1Y (TTM)-3.91%
EPS 3Y-13.45%
EPS 5Y-23.48%
EPS Q2Q%16.09%
Revenue 1Y (TTM)-1.69%
Revenue growth 3Y0.52%
Revenue growth 5Y-3.81%
Sales Q2Q%1.26%
3.2 Future
OGN is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 0.39% yearly.
Based on estimates for the next years, OGN will show a small growth in Revenue. The Revenue will grow by 0.38% on average per year.
EPS Next Y-7.23%
EPS Next 2Y-1.72%
EPS Next 3Y-0.29%
EPS Next 5Y0.39%
Revenue Next Year-2.64%
Revenue Next 2Y-1.79%
Revenue Next 3Y-0.96%
Revenue Next 5Y0.38%
3.3 Evolution
The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
OGN is valuated cheaply with a Price/Earnings ratio of 1.82.
Compared to the rest of the industry, the Price/Earnings ratio of OGN indicates a rather cheap valuation: OGN is cheaper than 98.43% of the companies listed in the same industry.
The average S&P500 Price/Earnings ratio is at 26.49. OGN is valued rather cheaply when compared to this.
OGN is valuated cheaply with a Price/Forward Earnings ratio of 1.80.
OGN's Price/Forward Earnings ratio is rather cheap when compared to the industry. OGN is cheaper than 98.95% of the companies in the same industry.
OGN's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 23.69.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 1.82 | ||
| Fwd PE | 1.8 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, OGN is valued cheaper than 96.34% of the companies in the same industry.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of OGN indicates a rather cheap valuation: OGN is cheaper than 99.48% of the companies listed in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 3.28 | ||
| EV/EBITDA | 5.89 |
4.3 Compensation for Growth
OGN has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-1.72%
EPS Next 3Y-0.29%
5. Dividend
5.1 Amount
OGN has a Yearly Dividend Yield of 1.12%. Purely for dividend investing, there may be better candidates out there.
The stock price of OGN dropped by -31.21% in the last 3 months. With lower prices the dividend yield is higher, but it may be a sign investors do not trust the long term dividend.
Compared to an average industry Dividend Yield of 6.46, OGN pays a better dividend. On top of this OGN pays more dividend than 90.58% of the companies listed in the same industry.
With a Dividend Yield of 1.12, OGN pays less dividend than the S&P500 average, which is at 2.31.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 1.12% |
5.2 History
OGN has been paying a dividend for over 5 years, so it has already some track record.
OGN has not decreased its dividend in the last 3 years.
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years3
5.3 Sustainability
31.54% of the earnings are spent on dividend by OGN. This is a low number and sustainable payout ratio.
DP31.54%
EPS Next 2Y-1.72%
EPS Next 3Y-0.29%
NYSE:OGN (12/8/2025, 10:44:01 AM)
7.1403
0 (0%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)
Earnings (Next)
Inst Owners80.37%
Inst Owner Change-5.51%
Ins Owners0.36%
Ins Owner Change2.03%
Market Cap1.86B
Revenue(TTM)6.30B
Net Income(TTM)501.00M
Analysts49.33
Price Target9.86 (38.09%)
Short Float %6.02%
Short Ratio2.62
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 1.12% |
Yearly Dividend1.16
Dividend Growth(5Y)N/A
DP31.54%
Div Incr Years0
Div Non Decr Years3
Ex-Date
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)5.63%
Min EPS beat(2)4.46%
Max EPS beat(2)6.8%
EPS beat(4)4
Avg EPS beat(4)6.63%
Min EPS beat(4)2.83%
Max EPS beat(4)12.44%
EPS beat(8)7
Avg EPS beat(8)6.8%
EPS beat(12)8
Avg EPS beat(12)3.85%
EPS beat(16)12
Avg EPS beat(16)6.75%
Revenue beat(2)2
Avg Revenue beat(2)1.21%
Min Revenue beat(2)0.69%
Max Revenue beat(2)1.72%
Revenue beat(4)2
Avg Revenue beat(4)0.16%
Min Revenue beat(4)-1.12%
Max Revenue beat(4)1.72%
Revenue beat(8)5
Avg Revenue beat(8)0.37%
Revenue beat(12)6
Avg Revenue beat(12)-0.37%
Revenue beat(16)10
Avg Revenue beat(16)0.1%
PT rev (1m)-10.77%
PT rev (3m)-24.48%
EPS NQ rev (1m)-16.14%
EPS NQ rev (3m)-14.34%
EPS NY rev (1m)-1.91%
EPS NY rev (3m)-1.43%
Revenue NQ rev (1m)-4.25%
Revenue NQ rev (3m)-3.47%
Revenue NY rev (1m)-0.8%
Revenue NY rev (3m)-0.36%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 1.82 | ||
| Fwd PE | 1.8 | ||
| P/S | 0.29 | ||
| P/FCF | 3.28 | ||
| P/OCF | 1.96 | ||
| P/B | 2.05 | ||
| P/tB | N/A | ||
| EV/EBITDA | 5.89 |
EPS(TTM)3.93
EY55.04%
EPS(NY)3.97
Fwd EY55.6%
FCF(TTM)2.18
FCFY30.49%
OCF(TTM)3.65
OCFY51.12%
SpS24.24
BVpS3.48
TBVpS-19.67
PEG (NY)N/A
PEG (5Y)N/A
Graham Number17.55
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 3.7% | ||
| ROE | 55.3% | ||
| ROCE | 12.48% | ||
| ROIC | 9.86% | ||
| ROICexc | 10.51% | ||
| ROICexgc | 25.64% | ||
| OM | 21.54% | ||
| PM (TTM) | 7.95% | ||
| GM | 55.04% | ||
| FCFM | 8.98% |
ROA(3y)7.82%
ROA(5y)11.49%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)12.92%
ROIC(5y)16.57%
ROICexc(3y)13.99%
ROICexc(5y)17.59%
ROICexgc(3y)39.55%
ROICexgc(5y)50.27%
ROCE(3y)16.36%
ROCE(5y)22.15%
ROICexgc growth 3Y-23.31%
ROICexgc growth 5Y-17.1%
ROICexc growth 3Y-16.16%
ROICexc growth 5Y-19%
OM growth 3Y-8.47%
OM growth 5Y-14.29%
PM growth 3Y-14.29%
PM growth 5Y-20.08%
GM growth 3Y-2.36%
GM growth 5Y-3.89%
F-Score5
Asset Turnover0.46
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 9.69 | ||
| Debt/FCF | 15.6 | ||
| Debt/EBITDA | 5.17 | ||
| Cap/Depr | 111.99% | ||
| Cap/Sales | 6.08% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 55.86% | ||
| Profit Quality | 112.97% | ||
| Current Ratio | 1.75 | ||
| Quick Ratio | 1.2 | ||
| Altman-Z | 1.2 |
F-Score5
WACC6.34%
ROIC/WACC1.56
Cap/Depr(3y)126.74%
Cap/Depr(5y)142.32%
Cap/Sales(3y)4.85%
Cap/Sales(5y)4.63%
Profit Quality(3y)60.39%
Profit Quality(5y)86.13%
High Growth Momentum
Growth
EPS 1Y (TTM)-3.91%
EPS 3Y-13.45%
EPS 5Y-23.48%
EPS Q2Q%16.09%
EPS Next Y-7.23%
EPS Next 2Y-1.72%
EPS Next 3Y-0.29%
EPS Next 5Y0.39%
Revenue 1Y (TTM)-1.69%
Revenue growth 3Y0.52%
Revenue growth 5Y-3.81%
Sales Q2Q%1.26%
Revenue Next Year-2.64%
Revenue Next 2Y-1.79%
Revenue Next 3Y-0.96%
Revenue Next 5Y0.38%
EBIT growth 1Y-8.87%
EBIT growth 3Y-7.99%
EBIT growth 5Y-17.56%
EBIT Next Year9.1%
EBIT Next 3Y3.83%
EBIT Next 5Y5.04%
FCF growth 1Y33.49%
FCF growth 3Y-35.21%
FCF growth 5Y-26.14%
OCF growth 1Y41.85%
OCF growth 3Y-27.44%
OCF growth 5Y-19.44%
ORGANON & CO / OGN FAQ
What is the fundamental rating for OGN stock?
ChartMill assigns a fundamental rating of 5 / 10 to OGN.
Can you provide the valuation status for ORGANON & CO?
ChartMill assigns a valuation rating of 8 / 10 to ORGANON & CO (OGN). This can be considered as Undervalued.
What is the profitability of OGN stock?
ORGANON & CO (OGN) has a profitability rating of 7 / 10.
Can you provide the expected EPS growth for OGN stock?
The Earnings per Share (EPS) of ORGANON & CO (OGN) is expected to decline by -7.23% in the next year.
Can you provide the dividend sustainability for OGN stock?
The dividend rating of ORGANON & CO (OGN) is 4 / 10 and the dividend payout ratio is 31.54%.